ROTE WILLIAM E. (Senior Vice President, R&D) sold 7.4% of their position (9.10K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $355.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/23/2026ACC: 0001698262-26-000003
Officer· Senior Vice President, R&D
Since Nov 2018
-9.10K
Net shares
Net seller
$355.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.10K
Price / share
$39.09
Trade value
$355.72K
% of position
7.4%
4/22/2026
123.09K→113.99K
Total
Net shares
−9.10K
Net value
-$355.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/22/2026 | S · Sale | −9.10K | $39.09 | $355.72K | 7.4% | 123.09K | 113.99K |
| Total | −9.10K | -$355.72K | ||||||
Derivative Transactions0
No derivative transactions reported